Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

B Cell Precursor Lymphoblastic Leukemia Patients with Good Treatment Response Have Low Levels of Erythroid Precursors

Barbora Vakrmanova, MD, Michaela Novakova, Martina Vaskova, Iveta Janotová, Elena Vodickova, MD, Monika Brüggemann, Eva Fronkova, MD PhD, Jan Trka, MD PhD, Jan Stary, MD PhD, Ondrej Hrusak, Ester Mejstrikova, MD PhD

Blood (2018) 132 (Supplement 1): 2832.

https://doi.org/10.1182/blood-2018-99-117976

Published: 2018

Journal Articles

Switching Towards Monocytic Lineage and Discordancy between Flow Cytometric and PCR Minimal Residual Disease Results Is a Hallmark Feature of DUX4 Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia

Michaela Novakova, Barbora Vakrmanova, MD, Lucie Slamova, Alena Musilova, Monika Brüggemann, Matthias Ritgen, MD, Eva Fronkova, MD PhD, Tomas Kalina, MD PhD, Jan Trka, MD PhD, Jan Stary, MD PhD, Martina Vaskova, Lucie Winkowska, Marketa Zaliova, Karel Fišer, PhD, Ondrej Hrusak, Ester Mejstrikova, MD PhD

Blood (2018) 132 (Supplement 1): 2825.

https://doi.org/10.1182/blood-2018-99-116575

Published: 2018

Journal Articles

Dissecting Childhood B-Other Acute Lymphoblastic Leukemia: Lower Frequency of Druggable Gene Fusions in European Population?

Marketa Zaliova, Jan Stuchly, Karel Fiser, Alena Musilova, Martina Slamova, Lucie Winkowska, Julia Starkova, Martina Vaskova, Jan Zuna, Jan Stary, Jan Trka

Blood (2017) 130 (Supplement 1): 3973.

https://doi.org/10.1182/blood.V130.Suppl_1.3973.3973

Published: 2017

Journal Articles

When Standard Markers Are Not Sufficient for Monitoring Minimal Residual Disease or Targeted Treatment: New Transcriptome Derived Flow Cytometry Markers for Switching B Cell Precursor Leukemias

Michaela Novakova, Alena Musilova, Lucie Slamova, Barbora Vakrmanova, Monika Brüggemann, Matthias Ritgen, Eva Fronkova, Tomas Kalina, Ondrej Hrusak, Jan Trka, Jan Stary, Martina Vaskova, Lucie Winkowska, Marketa Zaliova, Karel Fiser, Ester Mejstrikova

Blood (2017) 130 (Supplement 1): 3982.

https://doi.org/10.1182/blood.V130.Suppl_1.3982.3982

Published: 2017

Journal Articles

Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology

Lenka Hovorkova, Marketa Zaliova, Nicola C. Venn, Kirsten Bleckmann, Marie Trkova, Eliska Potuckova, Martina Vaskova, Jana Linhartova, Katerina Machova Polakova, Eva Fronkova, Walter Muskovic, Jodie E. Giles, Peter J. Shaw, Gunnar Cario, Rosemary Sutton, Jan Stary, Jan Trka, Jan Zuna

Blood (2017) 129 (20): 2771–2781.

https://doi.org/10.1182/blood-2016-11-749978

Published: 2017

Includes: Supplemental data

Journal Articles

Acute Leukemias of Ambiguous Lineage; Study on 247 Pediatric Patients

Blood (2015) 126 (23): 252.

https://doi.org/10.1182/blood.V126.23.252.252

Published: 2015

Journal Articles

Childhood Hyperdiploid Acute Lymphoblastic Leukemia

Marketa Zaliova, Martina Vaskova, Lenka Hovorkova, Ondrej Hrusak, Jan Stary, Jan Zuna

Blood (2015) 126 (23): 4990.

https://doi.org/10.1182/blood.V126.23.4990.4990

Published: 2015

Journal Articles

New Targets in Cytometric Investigation of Acute Leukemia Selected From Gene Profiling Studies

Martina Vaskova, PhD, Ester Mejstrikova, MD, PhD, Tomas Brdicka, PhD, Pavla Angelisova, PhD, Tomas Kalina, MD, PhD, Veronika Kanderova, MSc, Daniela Cerna, MSc, Martin Kovac, MSc, Jan Trka, MD, PhD, Fridtjof Lund-Johansen, MD, PhD, Jan Stary, M.D., Ondrej Hrusak, MD., PhD.

Blood (2011) 118 (21): 2536.

https://doi.org/10.1182/blood.V118.21.2536.2536

Published: 2011

Journal Articles

The Central Region of TEL (ETV6) Is Dispensable for the TEL/AML1 (ETV6/RUNX1) Leukemogenesis.

Marketa Zaliova, Claus Meyer, Gunnar Cario, Martina Vaskova, Rolf Marschalek, Jan Stary, Jan Zuna, Jan Trka

Blood (2009) 114 (22): 1601.

https://doi.org/10.1182/blood.V114.22.1601.1601

Published: 2009

Journal Articles

Proteomic Analysis of Soluble Proteins Important in Pediatric Acute Lymphoblastic Leukemia.

Martin Kovac, Denisa Petrackova, Vendula Pelkova, Martina Vaskova, Ester Mejstrikova, Tomas Kalina, Petra Volna, Silvie Bezouskova, Jaroslav Weiser, Ondrej Hrusak

Blood (2009) 114 (22): 1448.

https://doi.org/10.1182/blood.V114.22.1448.1448

Published: 2009

Journal Articles

NTAL Potentiates Glucocorticosteroid-Induced Apoptosis in T-ALL – in Vivo Observations and Experimental Model

Karel Svojgr, MD, Tatiana Burjanivova, MSc, Martina Vaskova, MSc, PhD, Tomas Kalina, MD, PhD, Tomas Brdicka, PhD, Jan Stary, MD, PhD, Jan Trka, MD, PhD, Jan Zuna, MD, PhD

Blood (2008) 112 (11): 5043.

https://doi.org/10.1182/blood.V112.11.5043.5043

Published: 2008

Journal Articles

Expression of Transmembrane Adaptors Is Specific in Distinct Childhood Acute Lymphoblastic Leukaemia Subgroups and Indicates Early Treatment Response in T-ALL.

Karel Svojgr, Tatiana Burjanivova, Martina Vaskova, Tomas Kalina, Jan Stary, Jan Trka, Jan Zuna

Blood (2007) 110 (11): 1433.

https://doi.org/10.1182/blood.V110.11.1433.1433

Published: 2007

Journal Articles

Biology of Childhood Acute Hybrid Leukemias in a Population-Based Study (Czech Pediatric Hematology Working Group).

Ester Mejstrikova, MD, Jana Volejnikova, Eva Fronkova, Tomas Kalina, Katerina Zdrahalova, Andrea Polouckova, Elena Vodickova, Zuzana Zemanova, Leona Reznickova, Martina Vaskova, Martin Kovac, Jan Zuna, Jan Trka, Jan Stary, Ondrej Hrusak

Blood (2007) 110 (11): 4247.

https://doi.org/10.1182/blood.V110.11.4247.4247

Published: 2007

Journal Articles

Standardized 4 Color Flow Cytometric Minimal Residual Disease Detection Failed To Overcome Regeneration Problems but Identifies Early Blast Clearence Predictive of Molecular Remission after Induction in Childhood B Lineage Leukemia.

Ester Mejstrikova, MD, Eva Fronkova, MD, PhD, Drago Batinic, MD, PhD, Klara Dubravcic, Flora Kiss, MD, Janos Kappelmayer, MD, PhD, Drorit Luria, PhD, Alice Suk Hang Cheng, BSc, PhD, Batia Stark, MD, PhD, Margaret Ng, MD, PhD, Yonna Leung, Bsc, Shai Izraeli, MD, PhD, Martina Vaskova, MSc, Katerina Zdrahalova, MD, Jan Trka, MD, PhD, Jan Stary, MD, PhD, Tomas Kalina, MD, PhD, Ondrej Hrusak, MD, PhD

Blood (2006) 108 (11): 1842.

https://doi.org/10.1182/blood.V108.11.1842.1842

Published: 2006

Journal Articles

Expression of LAT and PAG Adaptor Molecules in Blasts of Childhood Acute Lymphoblastic Leukaemias and in Normal B- and T-Precursors.

Tatiana Burjanivova, Martina Vaskova, Tomas Kalina, Jan Stary, Jan Trka, Jan Zuna

Blood (2006) 108 (11): 4306.

https://doi.org/10.1182/blood.V108.11.4306.4306

Published: 2006

Journal Articles

CD44 and CD27 Expression Delineates Stages of B Precursor Development Reflecting Recombination Status and Propensity to Leukemic Transformation.

Martina Vaskova, Eva Fronkova, MD,PhD, Julia Starkova, Tomas Kalina, MD,PhD, Ester Mejstrikova, MD, Ondrej Hrusak, MD,PhD

Blood (2006) 108 (11): 1671.

https://doi.org/10.1182/blood.V108.11.1671.1671

Published: 2006

Journal Articles

Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia by 4color Cytometry in International Multicenter Trial Minimini.

Ester Mejstrikova, MD, Drago Batinic, MD, PhD, Dubravcic Klara, Margareth Ng, MD, PhD, Yonna Leung, MSc, Janos Kappelmayer, MD, PhD, Drorit Luria, PhD, Shai Izraeli, MD, PhD, Tomas Kalina, MD, Martina Vaskova, MSc, Eva Fronkova, MD, Jan Stary, MD, DSc, Jan Trka, MD, PhD, Ondrej Hrusak, MD, PhD

Blood (2004) 104 (11): 1092.

https://doi.org/10.1182/blood.V104.11.1092.1092

Published: 2004

Journal Articles

Histone Deacetylase Inhibitors Are Capable to Modify Leukaemia-Specific Phenotype of TEL/AML1-Positive Leukaemic Cells.

Julia Starkova, MSc, Jozef Madzo, PhD, Tomas Kalina, MD, Martina Vaskova, MSc, Jan Trka, MD, PhD

Blood (2004) 104 (11): 1891.

https://doi.org/10.1182/blood.V104.11.1891.1891

Published: 2004

Journal Articles

CD33 - but Not Myeloid Antigens in General - Heralds Poor Prognosis in Childhood B Precursor ALL. Czech Pediatric Hematology Working Group (CPH) Population-Based Study.

Ester Mejstrikova, MD, Martina Vaskova, MSc, Tomas Kalina, MD, Jan Trka, MD, PhD, Jan Stary, MD, DSc, Ondrej Hrusak, MD, PhD

Blood (2004) 104 (11): 1078.

https://doi.org/10.1182/blood.V104.11.1078.1078

Published: 2004

Journal Articles

Microarray Guided Flow Cytometry: CD44 and CD27 Are Extremely Powerful Discriminators of ALL Subtypes.

Martina Vaskova, MSc, Ester Mejstrikova, MD, Tomas Kalina, MD, Jan Trka, MD, PhD, Jan Stary, MD, DSc, Ondrej Hrusak, MD, PhD

Blood (2004) 104 (11): 168.

https://doi.org/10.1182/blood.V104.11.168.168

Published: 2004

NARROW

B Cell Precursor Lymphoblastic Leukemia Patients with Good Treatment Response Have Low Levels of Erythroid Precursors

Switching Towards Monocytic Lineage and Discordancy between Flow Cytometric and PCR Minimal Residual Disease Results Is a Hallmark Feature of DUX4 Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia

Dissecting Childhood B-Other Acute Lymphoblastic Leukemia: Lower Frequency of Druggable Gene Fusions in European Population?

When Standard Markers Are Not Sufficient for Monitoring Minimal Residual Disease or Targeted Treatment: New Transcriptome Derived Flow Cytometry Markers for Switching B Cell Precursor Leukemias

Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology

Acute Leukemias of Ambiguous Lineage; Study on 247 Pediatric Patients

Childhood Hyperdiploid Acute Lymphoblastic Leukemia

New Targets in Cytometric Investigation of Acute Leukemia Selected From Gene Profiling Studies

The Central Region of TEL (ETV6) Is Dispensable for the TEL/AML1 (ETV6/RUNX1) Leukemogenesis.

Proteomic Analysis of Soluble Proteins Important in Pediatric Acute Lymphoblastic Leukemia.

NTAL Potentiates Glucocorticosteroid-Induced Apoptosis in T-ALL – in Vivo Observations and Experimental Model

Expression of Transmembrane Adaptors Is Specific in Distinct Childhood Acute Lymphoblastic Leukaemia Subgroups and Indicates Early Treatment Response in T-ALL.

Biology of Childhood Acute Hybrid Leukemias in a Population-Based Study (Czech Pediatric Hematology Working Group).

Standardized 4 Color Flow Cytometric Minimal Residual Disease Detection Failed To Overcome Regeneration Problems but Identifies Early Blast Clearence Predictive of Molecular Remission after Induction in Childhood B Lineage Leukemia.

Expression of LAT and PAG Adaptor Molecules in Blasts of Childhood Acute Lymphoblastic Leukaemias and in Normal B- and T-Precursors.

CD44 and CD27 Expression Delineates Stages of B Precursor Development Reflecting Recombination Status and Propensity to Leukemic Transformation.

Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia by 4color Cytometry in International Multicenter Trial Minimini.

Histone Deacetylase Inhibitors Are Capable to Modify Leukaemia-Specific Phenotype of TEL/AML1-Positive Leukaemic Cells.

CD33 - but Not Myeloid Antigens in General - Heralds Poor Prognosis in Childhood B Precursor ALL. Czech Pediatric Hematology Working Group (CPH) Population-Based Study.

Microarray Guided Flow Cytometry: CD44 and CD27 Are Extremely Powerful Discriminators of ALL Subtypes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only